Emergent BioSolutions | Ventas





Ventas Cambio Fecha
Acadia Pharmaceuticals USD 278.6M 14M 2025-09
Akebia Therapeutics USD 57.34M 10.84M 2025-03
ALKERMES USD 394.2M 3.5M 2025-09
Alnylam Pharmaceuticals USD 1.1B 150M 2025-12
Amarin USD 49.67M 23.07M 2025-09
ANI Pharmaceuticals USD 227.81M 16.44M 2025-09
BioMarin Pharmaceutical USD 776M 49M 2025-09
Coherus Biosciences USD 7.6M 46.54M 2025-03
Emergent BioSolutions USD 276.6M 6.1M 2023-12
Exact Sciences USD 878.38M 27.38M 2025-12
Exelixis USD 598.66M 860K 2025-12
Glaxosmithkline GBP 11.52B 3.54B 2025-09
Heron Therapeutics USD 32.81M 3.21M 2024-09
Ionis Pharmaceuticals USD 157M 295M 2025-09
Ironwood Pharmaceuticals USD 122.06M 36.82M 2025-09
Lexicon Pharmaceuticals USD 1.65M 520K 2024-06
Lonza CHF 3.58B 63M 2025-06
Merck USD 16.4B 880M 2025-12
Moderna USD 678M 342M 2025-12
Myriad Genetics USD 205.7M 7.4M 2025-09
Nektar Therapeutics USD 24.12M 635K 2024-09
Neurocrine Biosciences USD 805.5M 10.6M 2025-12
Pacira USD 179.52M 1.58M 2025-09
Pfizer USD 17.58B 880M 2025-12
PTC Therapeutics USD 211M 32.1M 2025-09
Sanofi EUR 11.3B 1.13B 2025-12
Sarepta Therapeutics USD 399.4M 211.69M 2025-09
United Therapeutics USD 799.5M 900K 2025-09
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12
Xoma USD 25K 5M 2024-09


Emergent BioSolutions Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.